ZOTAGCLA Trademark

Trademark Overview

On Tuesday, March 1, 2022, a trademark application was filed for ZOTAGCLA with the United States Patent and Trademark Office. The USPTO has given the ZOTAGCLA trademark a serial number of 97289806. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, August 8, 2024. This trademark is owned by Astellas Pharma Inc.. The ZOTAGCLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
zotagcla

General Information

Serial Number97289806
Word MarkZOTAGCLA
Filing DateTuesday, March 1, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, August 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP

Trademark Events

Event DateEvent Description
Friday, March 4, 2022NEW APPLICATION ENTERED
Friday, March 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 1, 2022ASSIGNED TO EXAMINER
Tuesday, December 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 30, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 30, 2023SOU EXTENSION 1 FILED
Wednesday, August 30, 2023SOU EXTENSION 1 GRANTED
Friday, September 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 8, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 8, 2024SOU EXTENSION 2 FILED
Thursday, February 8, 2024SOU EXTENSION 2 GRANTED
Friday, February 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 9, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 9, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, August 8, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 8, 2024SOU EXTENSION 3 FILED
Thursday, August 8, 2024SOU EXTENSION 3 GRANTED

Related Keywords

zotagcla cancer treatment preparations pharmaceutical